Related references
Note: Only part of the references are listed.Strategy To Discover Diverse Optimal Molecules in the Small Molecule Universe
Chetan Rupakheti et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Estimation of influential points in any data set from coefficient of determination and its leave-one-out cross-validated counterpart
Gergely Toth et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2A Antagonists/MAO-B Inhibitors
Silvia Rivara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-ones
Anne Stoessel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Lars Brichta et al.
TRENDS IN NEUROSCIENCES (2013)
Rational drug design for anti-cancer chemotherapy: Multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents
Alejandro Speck-Planche et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
A review of variable selection methods in Partial Least Squares Regression
Tahir Mehmood et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2012)
Comparative Studies on Some Metrics for External Validation of QSPR Models
Kunal Roy et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors
Karnati Konda Reddy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Exploring Activity Cliffs in Medicinal Chemistry Miniperspective
Dagmar Stumpfe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
On the Use of the Metric rm2 as an Effective Tool for Validation of QSAR Models in Computational Drug Design and Predictive Toxicology
K. Roy et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease
Angela Rampa et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Novel therapy in Parkinson's disease: adenosine A2A receptor antagonists
Nikoletta Szabo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Dual inhibition: a novel promising pharmacological approach for different disease conditions
Sazal Patyar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors
Swapnil Chavan et al.
MOLECULAR DIVERSITY (2011)
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Guillaume Lebon et al.
NATURE (2011)
The emergence of designed multiple ligands for neurodegenerative disorders
Werner J. Geldenhuys et al.
PROGRESS IN NEUROBIOLOGY (2011)
MULTIMODAL DRUGS AND THEIR FUTURE FOR ALZHEIMER'S AND PARKINSON'S DISEASE
Cornelis J. Van der Schyf et al.
MONOAMINE OXIDASES AND THEIR INHIBITORS (2011)
3D-QSAR in Drug Design - A Review
Jitender Verma et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Potentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase B
Daniele Bonivento et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
Devleena Shivakumar et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors
Pramod C. Nair et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues
Deidre van den Berg et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
Paul T. Francis et al.
MOVEMENT DISORDERS (2007)
Targeting adenosine A2A receptors in Parkinson's disease
Michael A. Schwarzschild et al.
TRENDS IN NEUROSCIENCES (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC)
N Vlok et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Present and future drug treatment for Parkinson's disease
AHV Schapira
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Alternatives to levodopa in the initial treatment of early Parkinson's disease
A Lees
DRUGS & AGING (2005)
8-(3-chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism
JF Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Beware of q(2)!
A Golbraikh et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2002)
Share Paper
